OPNT - Opiant Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue18,445.9969,897.5951,550
Cost of Revenue---
Gross Profit18,445.9969,897.5951,550
Operating Expenses
Research Development3,171.5992,808.7572,414.973
Selling General and Administrative8,181.63214,827.3176,034.52
Non Recurring---
Total Operating Expenses---
Operating Income or Loss7,092.765-7,738.479-6,899.493
Income from Continuing Operations
Total Other Income/Expenses Net18.356-63.887-110.148
Earnings Before Interest and Taxes7,131.087-7,814.256-7,009.641
Interest Expense--28.232
Income Before Tax7,131.087-7,814.256-7,037.873
Income Tax Expense550.474--
Minority Interest---
Net Income From Continuing Ops6,580.613-7,814.256-7,037.873
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income6,580.613-7,814.256-7,037.873
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares6,580.613-7,814.256-7,037.873